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RNA polymerase II (Pol II) can associate with regulatory elements far from promoters. For the murine
␤-globin locus, Pol II binds the ␤-globin locus control region (LCR) far upstream of the ␤-globin promoters,
independent of recruitment to and activation of the ␤major promoter. We describe here an analysis of where
Pol II resides within the LCR, how it is recruited to the LCR, and the functional consequences of recruitment.
High-resolution analysis of the distribution of Pol II revealed that Pol II binding within the LCR is restricted
to the hypersensitive sites. Blocking elongation eliminated the synthesis of genic and extragenic transcripts and
eliminated Pol II from the ␤major open reading frame. However, the elongation blockade did not redistribute
Pol II at the hypersensitive sites, suggesting that Pol II is recruited to these sites. The distribution of Pol II did
not strictly correlate with the distributions of histone acetylation and methylation. As Pol II associates with
histone-modifying enzymes, Pol II tracking might be critical for establishing and maintaining broad histone
modification patterns. However, blocking elongation did not disrupt the histone modification pattern of the
␤-globin locus, indicating that Pol II tracking is not required to maintain the pattern.
within the HNF4␣ locus, and a tracking mechanism was proposed to explain loop formation (19). An enhancer-bound
complex tracks along ⬃6.5 kb of chromatin toward the HNF4␣
promoter. This process is accompanied by the acetylation of
histones in the intervening region through coactivators recruited by the enhancer. In adult erythroid cells, the highly
acetylated ␤-globin LCR and the adult ␤-globin genes are
separated by an ⬃30-kb hypoacetylated region containing the
silent embryonic ␤-globin genes (15). As the hypoacetylated
subdomain is inaccessible to endonucleases and contains regions of high-level CpG dinucleotide methylation (20), the
subdomain likely precludes LCR-bound components from accessing active promoters through tracking.
Regardless of how looping occurs, juxtaposition of the LCR
with the promoter presumably allows direct access of LCRbound components to the promoter, thereby resulting in either
direct transfer of protein from the LCR to the promoter or
alteration of the nucleoprotein structure of the promoter. It
has been demonstrated that RNA polymerase II (Pol II) is
bound to the LCR in vivo (24, 25). Although the hematopoietic
activators GATA-1 and NF-E2 are required for Pol II recruitment to the ␤major promoter, Pol II recruitment to the LCR
is independent of NF-E2 (24). GATA-1 is necessary for Pol II
binding to HS1, HS2, and HS3 but not HS4 (25).
Since Pol II binds the LCR independent of its recruitment to
the promoter, we propose a long-range Pol II transfer (LPT)
mechanism in which Pol II is first recruited to the LCR, a step
which is enhanced by GATA-1. NF-E2 then provides a signal
for Pol II relocalization to the promoter, thereby stimulating
transcription. Recently, targeted deletion of the LCR in mice
revealed that Pol II recruitment to the ␤major promoter is only
partially dependent upon the LCR under conditions of phenylhydrazine-induced stress erythropoiesis (51). The LCR

Although well-defined basal transcription factors are required for transcription initiation, the assembly of these factors
on promoters is highly regulated through transcription factors
bound at promoters and at distal enhancers and locus control
regions (LCRs) (7, 23). Transcription factors recruit basal factors through protein-protein interactions (47) and indirectly by
recruiting chromatin-modifying coactivators, which increase
promoter accessibility (5, 32, 60). While it is easy to envision
how promoter-bound factors activate transcription, the mechanisms controlling transcription over a long distance on a chromosome are poorly understood. Evidence strongly supports a
looping mechanism, in which chromatin structure juxtaposes
distal regulatory elements with the gene, thereby allowing contact between factors bound at distant sites (6).
Looping has been implicated in the transcriptional control of
the murine ␤-globin genes (8, 56). The ␤-globin locus consists
of four genes arrayed in the order in which they are expressed
developmentally (Fig. 1A). High-level transcription of the
␤-globin genes requires upstream DNase I-hypersensitive sites
(HS1 to HS4) (12, 59) referred to as the LCR (Fig. 1A) (4, 10,
11, 17). As shown for erythroid cells from murine fetal liver,
the LCR is positioned close to the active adult ␤-globin genes
but not the inactive embryonic genes (8, 56), despite the fact
that the embryonic genes are closer to the LCR linearly on the
chromosome. However, determinants for establishing looping
have not been defined, nor it is known how looping activates
transcription, even though factors that bind the LCR and promoter in vivo are known (14, 25, 33, 52). Looping also occurs
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stimulated serine 5 phosphorylation of the carboxy-terminal
domain (CTD) of promoter-bound Pol II. Taken together with
the finding that LCR-bound Pol II is phosphorylated on serine
5 of the CTD (24), the LCR-dependent appearance of serine
5-phosphorylated Pol II at the promoter might be explained by
the transfer of serine 5-phosphorylated Pol II from the LCR to
the promoter.
Besides the ␤-globin locus, Pol II binds distal elements in
other loci. Pol II is recruited to the prostate-specific antigen
enhancer and tracks ⬃6 kb downstream to the promoter (37).
While tracking through the hypoacetylated subdomain of the
␤-globin locus is unlikely, for both the ␤-globin and prostatespecific antigen systems it has been postulated that Pol II
bound to a distal element gives rise to promoter-bound Pol II.
An alternate model for Pol II function at the ␤-globin LCR is
suggested by the presence of extragenic transcripts at the
␤-globin locus (2). Pol II transcription through the LCR, originating from an upstream ERV9 long terminal repeat (36, 46)
and from HS2 and HS3 in human erythroid cells (31), has been
proposed to mediate chromatin modification (16), potentially

by mobilizing Pol II-associated chromatin-modifying complexes (64, 65). Extragenic transcripts have also been detected
at the major histocompatibility complex class II locus (40) and
at the Drosophila bithorax complex (3). Despite these examples, the function of Pol II at distal elements is unclear. At
HNF4␣, Pol II cross-linking to an upstream enhancer was a
consequence of the enhancer-promoter interaction, a finding
which illustrates the importance of determining whether Pol II
binding to distal elements is independent of promoter binding
(19).
Insight into the function of Pol II at distal elements can be
obtained by analyzing exactly where Pol II resides within chromatin domains and how it is recruited. We describe here a
high-resolution analysis of Pol II binding at the LCR and
discriminate between models for how Pol II localizes to and
functions at the LCR.
MATERIALS AND METHODS
Cell culture. MEL (43) and CB3 (38) cells were maintained in Dulbecco’s
modified Eagle’s medium (Biofluids) containing 1% antibiotic-antimycotic
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FIG. 1. Highly restricted localization of Pol II within the ␤-globin LCR. (A) Organization of the murine Hbbd ␤-globin domain. The embryonic
(Ey and ␤H1) and adult (␤major and ␤minor) ␤-globin genes are shown as boxes, and HSs are shown as spheres. The locations of selected real-time
PCR amplicons used throughout the study are indicated below the locus. Intervening regions (IVR) represent sequences containing no known
functional elements and were analyzed in subsequent ChIP experiments. (B) High-resolution analysis of Pol II binding at the LCR. The relative
levels of Pol II binding at 20 sites within the LCR were determined by ChIP with DMSO-induced MEL cells. Black bars represent amplicons within
the murine HS cores, as defined by Hardison et al. (18). End points for these amplicons are at positions 258 to 308 (4core), 5700 to 5750 (3core),
11974 to 12046 (2core), and 15551 to 15626 (1core). Stacked gray (or black) and white bars represent the signals obtained with an anti-Pol II
antibody and control preimmune serum, respectively. Arrows indicate positions that were analyzed when enrichments for Pol II and preimmune
sera did not exceed 0.0002.
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Antibodies. Rabbit anti-Pol II (N-20; sc-899) was obtained from Santa Cruz
Biotechnology. Anti-acetylated histone H3 (06-599), anti-tetra-acetylated H4
(06-866), and anti-H3-meK4 (07-030) antibodies were obtained from Upstate
Biotechnology. Rabbit immunoglobulin G (Sigma) and preimmune serum were
used as controls.

RESULTS AND DISCUSSION
Pol II exhibits a highly restricted distribution within the
LCR. It has been shown that Pol II can be cross-linked to HS1
to HS4 of the ␤-globin LCR in multiple erythroid cell lines and
in fetal liver at 14.5 days postcoitum but not in nonerythroid
cells (24, 25). Pol II might be recruited to the LCR as a key
step in an LPT mechanism to provide Pol II to the highly active
␤major promoter. This model assumes that Pol II localizes
predominantly to the recruitment sites—the heteromeric protein complexes of the HSs. Alternatively, the presence of Pol II
at the LCR might reflect an ongoing process of transcription at
the LCR to generate extragenic transcripts (2). This model
assumes that Pol II resides throughout the LCR.
To test the possibilities outlined above, we used quantitative
ChIP to measure Pol II cross-linking to subregions of the LCR
in differentiated MEL cells (Fig. 1B). High-resolution measurements were made possible by use of formaldehyde-crosslinked chromatin fragments with an average size of ⬃400 bp.
Pol II bound the HS1 to HS4 cores, with the strongest binding
being at the HS2 core. Analysis of eight noncore sequences,
within 400 bp of the core amplicons, revealed substantial reductions in Pol II binding. Since the assay resolution depends
on the chromatin fragment size, small enrichments at the
flanking sequences might reflect Pol II occupancy at the cores.
Consistent with this possibility, little or no Pol II could be
detected at distances of greater than ⬃580 bp from the HSs.
These results show that Pol II is highly enriched at the HSs, but
not throughout the LCR.
The recruitment of Pol II to the LCR in MEL cells and in
primary definitive erythroid cells obtained from murine fetal
liver (24) might be indicative of a unique function of LCRbound Pol II at the adult stage of erythropoiesis. As the embryonic ␤-globin genes are considerably closer to the LCR than
the adult genes, which are separated from the LCR by the
broad hypoacetylated subdomain, the embryonic genes might
utilize a distinct mechanism to recruit Pol II. To test this
possibility, we examined whether Pol II associates with the
LCR in primitive EryP colonies derived from murine ES cells
through in vitro differentiation (Fig. 2A). This in vitro differentiation system recapitulates normal erythropoiesis and yields
large numbers of homogeneous EryP cells (21, 26, 27, 58, 62),
which express high levels of the embryonic globin genes (Fig.
2B).
Pol II bound the Ey promoter in EryP cells (Fig. 2C), consistent with the high activity of the embryonic ␤-globin genes in
this system. Pol II also bound the HS cores but not intergenic
site IVR5 located upstream of the ␤major promoter (Fig. 1A).
The amounts of Pol II at HS2, HS3, and HS4 were comparable
to the amount at the Ey promoter, consistent with our findings
for adult erythroid cells. The binding of Pol II to the HSs in
EryP cells suggests that LCR-bound Pol II is functionally important in both embryonic and adult stages of erythropoiesis.
The distribution of Pol II at the LCR is not dependent upon
transcriptional elongation. The Pol II distribution pattern
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(Gibco/BRL) and either 5% colt serum, 5% fetal calf serum (MEL), or 10% fetal
calf serum (CB3). Cells were induced to differentiate by incubation with 1.5%
dimethyl sulfoxide (DMSO; Sigma) for 4 days. MEL cells were treated with 100
M 5,6-dichlorobenzimidazole riboside (DRB) (Sigma) for 1 h in growth media.
Differentiation of murine ES cells into EryP colonies. Murine embryonic stem
(ES) cells were differentiated into primitive erythroid colonies (EryP colonies) as
described previously (26, 27). Briefly, day 4 embryoid bodies were collected,
trypsinized, and replated at 105 cells/ml in methylcellulose (Sigma) containing
10% plasma-derived serum (Antech, Houston, Tex.), 5% protein-free hybridoma
medium (Gibco/BRL), L-glutamine (2 mM), transferrin (300 g/ml; Boehringer
Mannhein), and monothioglycerol (4.5 ⫻ 10⫺4 M), together with 2 U of erythropoietin (Amgen, Thousand Oaks, Calif.)/ml. EryP colonies were collected 4
days later by digestion with cellulase (1 U/ml) for 20 min at 37°C. Cells were
resuspended in culture media, cross-linked with 0.4% formaldehyde for 10 min
at room temperature, and analyzed by chromatin immunoprecipitation (ChIP).
Quantitative real-time PCR ChIP assay. Quantitative ChIP analysis was performed as described previously (23, 25, 28). Samples were analyzed by quantitative real-time PCR (ABI Prism 7000) with primers designed by use of Primer
Express 1.0 software (PE Applied Biosystems) to amplify regions of 50 to 150 bp.
Primers were based on Hbbd haplotype sequences (GenBank accession numbers
Z13985, X14061, AF128269, and AF133300). The products in 25-l reaction
mixtures were measured on the basis of SYBR green fluorescence, and the
amounts of products were determined relative to a standard curve generated
from a titration of input chromatin. Analysis of denaturation curves postamplification showed that primer pairs generated single products.
Real-time RT-PCR. RNA was prepared from the same cell cultures as those
used for ChIP. Total RNA was purified with Trizol (Gibco/BRL). For real-time
reverse transcriptase (RT) PCR (RT-PCR), total RNA was purified, and 1 g of
RNA was used to prepare cDNA by annealing with 250 ng of a 5:1 mixture of
random and oligo(dT) primers heated at 68°C for 10 min. This step was followed
by incubation with RT (Superscript II; Gibco/BRL), 10 mM dithiothreitol
(DTT), RNasin (Promega), and 0.5 mM deoxynucleoside triphosphates at 42°C
for 1 h. The mixture was diluted to 150 l and heat inactivated at 95°C for 5 min.
The RT-PCR mixture (25 l) contained 2 l of cDNA solution and the appropriate primers. Product accumulation was monitored on the basis of SYBR green
fluorescence. Relative expression levels were determined from a standard curve
of serial dilutions of cDNA samples.
Primers for real-time PCR. Primers for real-time PCR were as follows (5⬘-3⬘):
5/4, CAAATCCGTTATCAAGTTTAGGAAAAA and CACACCTGAAAAAG
TGCTTCATTCT; 4core, GAGATCCTGCCAAGACTCTGATAATACTA and
CCTGGCTTCCTGGTCCAGTAG; 4/3-A, GGAATTCCCATGATAGATGTA
ATATCATT and AAGGGTCAAAAAAGGCTAGAGACTT; 4/3-B, CACGA
GTTTCCTTTCATGCTTATG and CCAGCCCTTCTGGAACTTCTC; 4/3-C,
AAGCCAGGTGTGGTAGCAGAAG and TGGCCTCGAACCTCAAAAAT;
3core, CTAGGGACTGAGAGAGGCTGCTT and ATGGGACCTCTGATAG
ACACATCTT; 3/2-A, TTGGTATCCTGAGAGGGTATTTGAT and TGCAG
AACTGTGTCTTTCACTTGAT; 3/2-B, TTAAAGCCTCATTATCTCCAAAC
CA and GTGTGCACTGGGTGGGTAGA; 3/2-C, CTTTCTAAAAGGCATCT
TCACTGAGAA and CTTTGTAGAGATTGTAAGGTTAGAAATCCAT;
3/2-D, CCTGAATGACTGTTAAACTTCCTACACA and AAAAAAATGCA
GAGGCTCGTTAAT; 2core, AGTCAATTCTCTACTCCCCACCCT and ACT
GCTGTGCTCAAGCCTGAT; 2/1-A, GACTTTTGTTCATAAACTATGCAA
TTGTT and GCCCATTCCAAATAGCATTTCA; 2/1-B, TCAAAGATCAAG
TGACCATCCAAA and ACCTTGGAAGTTCTACTAGATTGGAAA; 1core,
CAGATCCTCAAACACTCTCCCATAA and TGCCTTCTTTGTCCCATC
ATT; 1/Ey-A, GTCAGAAATTGTAACACAGGCTTGA and CCAAGGTGCC
AAGAGACCAA; 1/Ey-B, TTCAGGAAATTCCCTAAGTTATACCTTC and
TAGCTAGGCATACCTCTTCAGCATTTA; 1/Ey-C, CCTTTTGAAAATCAT
ATTCAGCCATA and AAGTGTTGCCTCAAAAGCCATAC; 1/Ey-D, ATCCA
TTCCCAGAGCTTTGTACA and AACCCCAAGTCTGAGTGTTTGC; 1/Ey-E,
AGGCAGGTTGGAGGACAACTT and GGTCACAGTTTGGCTTTCCTA
TTT; Ey promoter, ATGACCTGGCTCCACCCAT and TCTTTGAAGCCATTG
GTCAGC; ␤H1 promoter, AGGTCCAGGGTGAAGAATAAAAGG and ATCT
CAAGTGTGCAAAAGCCAGA; ␤major promoter, CAGGGAGAAATATGCT
TGTCATCA and GTGAGCAGATTGGCCCTTACC; ␤major (intron 2), CTTCT
CTCTCTCCTCTCTCTTTCTCTAATC and AATGAACTGAGGGAAAGGAA
AGG; ␤major 3⬘, GCCCTGGCTCACAAGTACCA and TTCACAGGCAAGAG
CAGGAA; ␤minor promoter, GAGCCAGCATTGGGTATATAAAGC and ACA
GACTCAGAAGCAAACGTAAGAAG; IVR3, TGTGCTAGCCTCAAGCT
CACA and TCCCAGCACTCAGAAGAAGGA; IVR5, GTATGCTCAATTCAA
ATGTACCTTATTTTAA and TTACCTCTTTATTTCACTTTTACACATAGC
TAA; and IVR16, TGGCCATTTTTACTATGTTAATTTTGC and TAGACTTG
TCATGGTTATGGATTGG.
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shown in Fig. 1B can be explained by a mechanism in which Pol
II is recruited directly to the HSs, but it is instructive to consider other mechanisms. As human HS2 and HS3 function as
promoters (31, 50), a small fraction of Pol II, undetectable by
ChIP, might engage in extragenic transcription. Alternatively,
Pol II might be recruited upstream of the HSs, and the accumulation of Pol II at the HSs might reflect strong pausing of
elongating Pol II at the HSs. However, no upstream initiation
sites within the murine ␤-globin locus have been described. Pol
II pausing is an established mechanism of transcriptional control. For example, Pol II is transcriptionally engaged, but
paused, at the 5⬘ end of the inactive hsp70 gene of Drosophila
melanogaster (49). Similarly, Pol II is paused on the inactive
human c-myc promoter-proximal region (30). Despite examples of Pol II pausing on genic sites, it is unclear what function
Pol II pausing would have in extragenic transcription.
If the pattern of Pol II binding within the ␤-globin LCR
reflects Pol II processivity and pausing, the elimination of

elongation by Pol II should redistribute Pol II at the HSs. To
test this possibility, we subjected DMSO-induced MEL cells to
a 1-h treatment with the Pol II elongation inhibitor DRB (9).
DRB inhibits the kinase activities of P-TEFb and TFIIH,
thereby preventing phosphorylation of the Pol II CTD (39).
CTD phosphorylation is necessary for elongation but not for
Pol II recruitment (34, 44). Treatment of MEL cells with DRB
reduced the level of unprocessed primary ␤major transcripts
68-fold, as determined by quantitative real-time RT-PCR (Fig.
3A). The amount of primary transcripts remaining following
DRB treatment was only ⬃3-fold higher than that in controls
lacking RT, indicating that nearly complete repression was
achieved. In addition, low-level extragenic transcripts were detected at multiple LCR sites but not at intergenic site IVR3
(Fig. 3A). Like that of ␤major primary transcripts, the synthesis
of extragenic transcripts was eliminated by DRB.
To provide additional evidence that Pol II elongation was
eliminated by DRB, we used quantitative ChIP to measure Pol
II binding to the ␤major promoter and to the ␤major coding
region (Fig. 3B). Following DRB treatment, Pol II levels at
intron 2 and exon 3 were strongly reduced relative to background levels, while Pol II levels at the promoter were reduced
only ⬃2-fold. Under conditions in which DRB eliminated Pol
II binding to the coding region of ␤major, no reduction in Pol
II levels occurred at the HSs (Fig. 3B). Taken together with the
highly restricted distribution of Pol II at the HSs (Fig. 1B),
these results provide strong evidence against a model in which
the majority of LCR-bound Pol II actively tracks throughout
the LCR.
Differential distributions of histone modifications and Pol II
at the LCR. Recruitment of Pol II to HS1, HS2, and HS3 of the
LCR is facilitated by prior GATA-1 binding (25). GATA-1
binding also induces CBP recruitment and increases the acetylation of histones H3 and H4 at HS3 (33). Given that histone
tail modifications can serve as recognition sites for protein
binding (29, 54), in addition to modulating higher-order chromatin folding (13), we examined whether the histone modification state of the LCR might be a critical determinant of Pol
II recruitment to the LCR. Accordingly, the pattern of Pol II
binding at the LCR might correlate with the distribution of one
or more histone modifications. Alternatively, histone modifications might indirectly increase Pol II access to the LCR by
inducing a higher-order chromatin structure transition involving multiple nucleosomes. In this situation, the distributions of
specific histone modifications and Pol II binding would not
necessarily correlate. Finally, Pol II might localize to the LCR
independently of specific histone modifications. As in the second model, the distributions of Pol II binding and histone
modifications would not correlate.
To investigate the mechanism of Pol II recruitment, we used
antibodies against diacetylated H3 (K9 and K14) (Fig. 4B),
H3-meK4 (Fig. 4C), and tetra-acetylated H4 (Fig. 4D) to generate high-resolution maps of these modifications at the
⬃15-kb LCR. Compared to Pol II binding, which was highest
at the HS cores (Fig. 1B), histone modifications were more
broadly distributed. Diacetylation of H3 has been linked to the
activation of numerous genes (13, 48), and diacetylated H3 has
been shown to bind the double bromodomains of TAFII250 at
the beta interferon promoter (1). At the ␤-globin promoters,
both NF-E2 and GATA-1 are required for the establishment
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FIG. 2. Pol II binds the LCR in primitive EryP colonies derived
from murine ES cells. (A) Primitive EryP colonies were generated by
in vitro differentiation of murine ES cells. (B) Real-time PCR analysis
of the expression of embryonic ␤-globin gene ␤H1 in EryP and MEL
cells. The graph shows the relative levels of ␤H1 mRNA transcripts
normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA transcripts. Note that ␤H1 expression in EryP cells exceeded
expression in MEL cells by more than 6 orders of magnitude. (C) ChIP
analysis of Pol II binding to HS2, HS3, and HS4, the active Ey promoter, and intergenic site IVR5. The graph shows the relative intensities of PCR products from two (IVR5) or three independent experiments (mean and standard error of the mean).
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of high-level H3 acetylation (24, 28) and for Pol II recruitment
(25). Within the LCR, H3 acetylation was maximal at or near
the HS cores, with similar levels of acetylation at all HSs (Fig.
3A). Unlike Pol II binding (Fig. 1B), H3 acetylation was not
necessarily maximal at the cores. With the exception of HS2,
the peaks of acetylation occurred at sequences flanking the
cores. At HS1 and HS4, the levels of H3 acetylation were 3.5and 2.6-fold higher, respectively, at sites less than 300 bp downstream from the cores. At locations 650 bp to 2 kb away from
the cores, H3 acetylation was considerably reduced, with most
sites exhibiting only small amounts of enrichment compared
with those for the silent Ey promoter.
Like diacetylated H3, H3-meK4 is enriched in active yeast,
chicken, and Tetrahymena chromatin (35, 41, 42, 55). A limited
analysis of the distribution of H3-meK4 within the murine
␤-globin locus (28) revealed a distribution more restricted than
that predicted from yeast and chicken studies. H3-meK4 levels
were high at HS2 and at the active ␤-globin genes but were low
at intergenic sites adjacent to the active genes in adult ery-

throid cells. Other sequences within the LCR were not examined previously. The patterns of acetylated H3 (Fig. 4B) and
H3-meK4 (Fig. 4C) were similar, with maximal H3-meK4 enrichment at the HSs and smaller amounts of enrichment at
external sites. However, the H3-meK4 level was more variable
than that of acetylated H3 at the HSs. For example, the H3meK4 level was higher at HS1 than at other HSs.
Acetylated H4 is a less likely candidate for the recruitment
of Pol II than acetylated H3, since NF-E2-dependent activation of the ␤major promoter involves the induction of H3
acetylation at the promoter, with only a small increase in H4
acetylation (24, 28). Moreover, the induction of H4 acetylation
at inactive embryonic ␤-globin genes by trichostatin A-dependent inhibition of histone deacetylase activity failed to stimulate Pol II recruitment and transcriptional activation of these
genes (20). Nonetheless, the acetylation of H4 at K5 and K12
is thought to stabilize the binding of TFIID to promoters
through interactions with the TAFII250 bromodomains (22).
At the LCR, acetylated H4 (Fig. 4D) was more broadly dis-
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FIG. 3. Blocking of transcriptional elongation eliminates Pol II from ␤major but does not redistribute LCR-bound Pol II. MEL cells were
differentiated with 1.5% DMSO for 4 days and then treated with 100 M DRB for 1 h prior to ChIP analysis. (A) Elimination of Pol II-generated
genic and extragenic transcripts by DRB treatment. cDNAs were prepared from total cellular RNAs from MEL cells treated with DRB or with
vehicle (DMSO). Primers specific to a region within the second intron of ␤major (␤maj I2) or to extragenic sites within the ␤-globin locus were
used to detect unprocessed primary transcripts. To control for potential contaminating DNA, RT was omitted from control reactions (⫺RT). RNA
was analyzed in two or three independent experiments. (B) ChIP analysis of Pol II binding at the ␤-globin locus following DRB treatment. The
positions of PCR primers to amplify LCR sequences are shown in Fig. 1. Pol II binding at the ␤major promoter (␤maj pro), within the second intron
(␤maj I2), and within the third exon (␤maj 3⬘) was examined. The graphs show the relative intensities of PCR products from three or four
independent experiments. PI, rabbit preimmune serum. Data are the means and standard errors of the means.
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tributed than Pol II (Fig. 1B), acetylated H3 (Fig. 4B), or
H3-meK4 (Fig. 4C). Certain sites between the HSs, for example, amplicons 3/2-B and 2/1-B, exhibited as much H4 acetylation as the HSs. Like the levels of acetylated H3 and H3meK4, the level of acetylated H4 at the HSs was highest at sites
flanking the cores.

Superficially, the distributions of Pol II binding and histone
modifications are similar, with peaks at or near the HS cores
and reduced levels between the cores. However, the differences in their distributions demonstrate that Pol II occupancy
does not occur exclusively at sites enriched in the histone
modifications examined. A linear regression analysis comparing the levels of H3 acetylation (Fig. 5A), H3 dimethylation
(Fig. 5B), and H4 acetylation (Fig. 5C) to the levels of Pol II
binding at the sites shown in Fig. 1B confirmed the lack of
correlation. A correlation (R2) of 0.741 was observed between
the levels of H3 acetylation and H4 acetylation (Fig. 5D),
although as noted above, H4 levels were higher than H3 levels
at regions between the HSs. While other histone modifications
might mediate Pol II recruitment, the restricted distribution of
Pol II at the HSs is consistent with the direct recruitment of Pol
II to the HSs by DNA-bound factors, rather than attraction
through the recognition of acetylated H3 and H4 and H3meK4.
Localization of Pol II to the LCR is independent of recruitment to the ␤-globin promoters. Chromatin of the murine
␤-globin locus adopts a looped structure, in which the HSs are
in close proximity to the active genes (8, 56). Thus, direct
interactions between the LCR and promoters may be required
for Pol II binding to the LCR, possibly resulting in the simultaneous cross-linking of factors to both sites. In MEL cells and
in murine fetal liver, the adult ␤-globin genes are active, and
Pol II resides at both the LCR and the active adult ␤-globin
promoters. In contrast, in CB3 cells, a MEL cell line lacking
the hematopoietic cell-specific subunit of NF-E2, p45/NF-E2
(38), the adult ␤-globin genes are not expressed and Pol II is
absent from the ␤major promoter (24). Importantly, Pol II
binds the LCR in CB3 cells. In the GATA-1-null cell line G1E
(63), Pol II levels are reduced at the ␤major promoter and at
HS1 to HS3 but are unchanged at HS4, compared to those in
G1E cells expressing an activated estrogen receptor fused to
GATA-1 (25). These results indicate that Pol II binds the HSs
independently of the binding of Pol II to the ␤-globin promoters.
The analysis described above with CB3 cells (24) was carried
out with semiquantitative ChIP in which the intensity of
ethidium bromide bands was measured densitometrically. This
analysis yielded considerably lower signal/noise ratios than our
quantitative real-time PCR-based ChIP (20, 21, 28). In addition, Pol II binding was not assessed previously at all promoters of the ␤-globin locus. Given the major mechanistic implications of Pol II residing at the LCR independently of the
promoter, we comprehensively analyzed and quantitated Pol II
occupancy at all promoters of the locus and at HS1 to HS4 of
the LCR in CB3 cells (Fig. 6). Without p45/NF-E2, little or no
Pol II was detected at the embryonic and adult ␤-globin promoters. The ⬃2-fold increase in Pol II signals relative to preimmune antibody controls was observed at multiple nonpromoter sites (for example, IVR3 and IVR16). At the LCR, the
increases in Pol II signals relative to preimmune controls were
21-fold (HS4), 4.8-fold (HS3), 10.5-fold (HS2), and 17.4-fold
(HS1). The lower enrichment at HS3 compared to that seen in
MEL cells expressing p45/NF-E2 suggests that the recruitment
of Pol II to HS3 requires NF-E2. The results shown in Fig. 6
definitively confirm the previous finding that p45/NF-E2 is not
essential for Pol II binding within the LCR (24) and provide
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FIG. 4. High-resolution analysis of histone modifications at the
LCR. (A) Positions of HS core primers within the murine ␤-globin
domain are shown. (B to D) The relative levels of diacetylated H3 (B),
H3-meK4 (C), and multiacetylated H4 (D) within the LCR were determined by ChIP with DMSO-induced MEL cells. The positions examined by PCR were the same as those examined for Pol II binding in
Fig. 1B. As in Fig. 1B, black bars represent amplicons within the
murine HS cores. Signals obtained upon ChIP with control preimmune
serum are the same as those in Fig. 1B, as these experiments were
conducted simultaneously. The graphs show the relative intensities of
PCR products from three or more independent experiments.
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strong evidence that Pol II recruitment to the LCR does not
require concomitant binding to the promoter. Accordingly,
cross-linking of Pol II to the LCR does not result from promoter-bound Pol II being brought into close proximity to the
LCR, since no Pol II was detected at the promoters in CB3
cells.
In contrast to the results shown in Fig. 6, the activation of
HNF4␣ transcription results in Pol II recruitment to the promoter, prior to detectable enhancer-promoter interactions
(19). The subsequent detection of Pol II at the enhancer ⬃6.5
kb upstream of the promoter was suggested to be a consequence of its simultaneous cross-linking to the two regions.
The ␤-globin and HNF4␣ systems differ considerably in that
the large, multicomponent ␤-globin LCR is far upstream of the
adult ␤-globin genes, while the small HNF4␣ enhancer is relatively close to HNF4␣. Furthermore, ␤-globin is considerably
more abundant than the activator HNF4␣; therefore, the rates
of transcription of the two genes are likely to differ greatly,
with ␤-globin transcription being much higher. An additional
study found Pol II associated with a distal regulatory element
⬃2.3 kb upstream of a major histocompatibility complex promoter (40). However, this analysis did not reveal whether Pol
II localizes to this distal element independently of promoter
binding.
Pol II elongation is not required to maintain the erythroidspecific histone modification pattern of the ␤-globin locus.

FIG. 6. Pol II binding at the LCR is independent of Pol II recruitment to the ␤major promoter. Comparison of Pol II binding by ChIP
at ␤-globin gene promoters and HS cores in p45/NF-E2-null CB3 cells.
CB3 cells were cultured with 1.5% DMSO for 4 days prior to ChIP
analysis. The ⬃2-fold enrichment of Pol II compared to preimmune
serum that was observed at the promoters was also evident at extragenic sites IVR3 and IVR16 (for the positions of these sites, see Fig.
1A). The graph shows the relative intensities of PCR products from
three or more independent experiments (mean and standard error of
the mean).
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FIG. 5. Lack of correlation between the distributions of Pol II binding and specific histone modifications. (A to C) Linear regression analyses
of values obtained from Fig. 1B and 4B to D for Pol II binding and either H3 diacetylation (A), H3-K4 dimethylation (B), or multisite H4
acetylation (C) were carried out for the 20 sites within the LCR shown in Fig. 1B. (D) For comparison, a correlation plot is shown for H3
diacetylation and H4 acetylation.
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FIG. 7. Maintenance of the erythroid-specific composite histone
modification pattern of the ␤-globin locus does not require ongoing
transcriptional elongation by Pol II. Samples analyzed by ChIP for Pol
II binding in Fig. 3 were also used to detect DRB-induced changes in
histone acetylation and H3-meK4 at the ␤major gene and at the LCR.
The graphs show the relative intensities of PCR products from three or
four independent experiments (mean and standard error of the mean).
PI, rabbit preimmune serum.

fications. The possibility that the histone modifications are
sufficiently stable such that preestablished modifications persist
during the time course of the experiment is unlikely, given that
the turnover of histone acetylation within active chromatin of
vertebrate cells involves half-lives of less than 10 min (61).
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Despite the arguments presented above, one cannot unequivocally rule out the possibility that a small fraction of the Pol
II-generating extragenic transcripts functions to establish
and/or maintain histone modifications. It has been suggested
that Pol II processivity and/or the resulting extragenic transcripts regulate the chromatin structure of tissue-specific loci
(2, 16). The activation of ␤major transcription correlates with
increased acetylated H3 and H3-meK4 levels at the promoter
and within the coding region and with a smaller increase in the
acetylated H4 level preferentially within the coding region (24,
28). Although we believe that these changes in histone modifications are required for high-level transcription and, as such,
precede Pol II recruitment and elongation, this notion has not
been proven. Alternatively, histone-modifying enzymes directly interact with the transcriptional machinery, and such
enzymes might utilize elongating Pol II to modify histones over
a broad region (45, 57). Consequently, the elimination of Pol II
elongation should prevent the modifying enzymes from reaching their targets and therefore should change the histone modification pattern.
To determine whether Pol II elongation is required to establish and/or maintain the erythroid-specific composite histone modification pattern of the ␤-globin locus, we tested
whether a 1-h treatment of cells with DRB reconfigures the
histone modification pattern. The consequences of the DRBinduced elongation block for the histone modifications of the
␤major gene were mild compared to the results seen in the
NF-E2-null CB3 cell line, in which ␤major is transcriptionally
silent. Despite the nearly complete elimination of transcription
(Fig. 3A), DRB treatment of induced MEL cells did not
change H3 acetylation at the promoter, and only a small reduction (⬍2-fold) was apparent within ␤major (Fig. 7A). In
contrast, in a previous study (28), the loss of NF-E2 in CB3
cells reduced H3 acetylation 3-fold at the promoter and 12-fold
within exon 3 relative to the results seen in MEL cells. Both
acetylation and transcription were rescued upon the expression
of p45/NF-E2. H3-meK4 was only slightly affected by DRB
treatment (Fig. 7B), despite the 5-fold (promoter) and 31-fold
(exon 3) reductions seen in a previous study upon the loss of
NF-E2 in CB3 cells (28). H4 acetylation was unchanged following DRB treatment (Fig. 7C), despite the 3.5-fold reduction seen at exon 3 in CB3 cells in a previous study (28). These
results indicate that transcriptional elongation is not required
to maintain the erythroid-specific composite histone modification pattern at the ␤major gene.
Besides the proposed roles for transcription elongation in
establishing and maintaining histone modification patterns at
genes, Pol II tracking has also been suggested to mediate the
remodeling of large extragenic regions (16, 57). Since low
levels of DRB-sensitive transcripts were detected at the LCR
(Fig. 3A), we tested whether DRB treatment altered histone
modifications at the HSs in differentiated MEL cells. Like the
results for ␤major, no significant reductions in histone acetylation and methylation were detected (Fig. 7). Thus, DRB
treatment blocked genic and extragenic transcription of the
␤-globin locus and abolished Pol II binding downstream of the
␤major promoter yet had little or no effect on Pol II binding to
the HSs or on histone modifications at ␤major and at the HSs.
The lack of DRB sensitivity of the modification patterns indicates that elongation is not required to maintain these modi-
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Similar kinetics have been observed for the loss of pentaacetylated H4 from transcriptionally competent chromatin in
immature chicken erythrocytes expressing adult ␤-globin (53).
In summary, we have shown that Pol II localizes in a highly
restricted manner to the HSs of the LCR, with the highest
occupancy being at the HS cores. While the HSs were strongly
enriched in acetylated histones H3 and H4 and in H3-meK4,
the distributions of the modifications did not strictly correlate
with sites of Pol II occupancy. As a blockade of transcriptional
elongation did not redistribute Pol II within the LCR or reconfigure the erythroid-specific composite histone modification pattern of the ␤-globin locus, it is unlikely that Pol II
movement throughout the LCR maintains the histone modification pattern. The highly restricted localization of Pol II and
the lack of evidence for transcription-dependent histone modification are consistent with a mechanism in which the LCR
recruits Pol II, which then undergoes transfer to the promoters
in a highly regulated fashion. We speculate that LPT considerably enhances the efficiency of Pol II recruitment achieved by
direct recruitment to promoters and therefore would be utilized by loci that exhibit high rates of transcription.
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